Any truly effective response against either disease will have to be comprehensive: one that scales up existing programs for prevention and care while quickly rolling out new biomedical tools and strategies to reduce transmission -- especially vaccines.
As the world's attention has been fixated on the fight against HIV and AIDS, something ironic and perverse has happened. We have failed to invest enough resources to mount an effective fight against tuberculosis (TB), the number-one killer of people living with HIV.
This week donors are meeting to discuss the Global Fund's progress in fighting the three killer diseases: AIDS, TB and malaria. Looking at the future, one thing is clear: we need sufficient funds and we need to spend them right.
Amongst the bayonets and bravado, there was no discussion about how either candidate would use the office of the president to address the top global health challenges. Neglecting to head off threats from superbugs now will lead to calamitous consequences later.
An international team led by researchers from the U.S. Centers for Disease Control and Prevention published new data on Thursday showing that an epidemic of completely drug-resistant, airborne disease is creeping steadily toward us.
Mr. and Mrs. Mkoko are one of four families in the film They Go to Die -- Mr. Mkoko, who was present at the screening, is the only one of four miners who has survived the hardships resulting from his time in the mines.
When I speak to Africans living with HIV, when I speak to African AIDS activists and when I speak to African leaders fighting AIDS, TB and malaria, they all express a profound gratitude for the global solidarity the world has expressed to them.
More people die from TB today than ever before -- 1.4 million people each year, according to the World Health Organization. Part of the reason is that TB is still diagnosed in most parts of the world using a method invented in the late 19th century.
In order to ensure that new tools are developed and today's treatments are provided, governments must prioritize tuberculosis as a public health priority and close the projected gaps in domestic and international funding.